Homology Medicines Buy Hold or Sell Recommendation

FIXXDelisted Stock  USD 1.09  0.06  5.83%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Homology Medicines is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Homology Medicines given historical horizon and risk tolerance towards Homology Medicines. When Macroaxis issues a 'buy' or 'sell' recommendation for Homology Medicines, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
In addition, we conduct extensive research on individual companies such as Homology and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Homology Medicines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Execute Homology Medicines Buy or Sell Advice

The Homology recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Homology Medicines. Macroaxis does not own or have any residual interests in Homology Medicines or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Homology Medicines' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Homology MedicinesBuy Homology Medicines
Not Rated
For the selected time horizon Homology Medicines has a Risk Adjusted Performance of 0.0406, Jensen Alpha of 0.1483, Total Risk Alpha of (0.27), Sortino Ratio of 0.0138 and Treynor Ratio of (2.93)
We provide advice to complement the regular expert consensus on Homology Medicines. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Homology Medicines is not overpriced, please check out all Homology Medicines fundamentals, including its earnings per share, total asset, as well as the relationship between the total debt and revenue . Given that Homology Medicines is a hitting penny stock territory we urge to closely look at its price to earning.

Homology Medicines Trading Alerts and Improvement Suggestions

Homology Medicines is now traded under the symbol QTTB. Please update your portfolios or report it if you believe this is an error. Report It!
Homology Medicines is not yet fully synchronised with the market data
Homology Medicines has some characteristics of a very speculative penny stock
Homology Medicines has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (95.14 M).
Homology Medicines currently holds about 201.07 M in cash with (96.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Homology Medicines Returns Distribution Density

The distribution of Homology Medicines' historical returns is an attempt to chart the uncertainty of Homology Medicines' future price movements. The chart of the probability distribution of Homology Medicines daily returns describes the distribution of returns around its average expected value. We use Homology Medicines price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Homology Medicines returns is essential to provide solid investment advice for Homology Medicines.
Mean Return
0.15
Value At Risk
-5.61
Potential Upside
5.77
Standard Deviation
3.71
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Homology Medicines historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Exercise or conversion by Arthur Tzianabos of 14280 shares of Homology Medicines subject to Rule 16b-3 [view details]

Homology Medicines Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Homology . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Homology Medicines Buy or Sell Advice

When is the right time to buy or sell Homology Medicines? Buying financial instruments such as Homology Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Homology Medicines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Homology Stock

If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences